Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijing Sun

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Investigational New Drugs|January 24, 2017
A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine aloneJames M Cleary, Lee S Rosen, Kenichiro Yoshida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203Weijing Sun, Mark Powell, Peter J O'Dwyer, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 8, 2023
A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicityAnup Kasi, Pramod Gaudel, Manidhar Lekkala, et al.
JAMA Network Open|December 16, 2020
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysisAnup Kasi, Saqib Abbasi, Shivani Handa, et al.
Fortune Journal of Health Sciences|September 22, 2023
Microsatellite Instability with BRAF V600E Associated with Delayed Presentation but Poor Survival in Stage III Colorectal CancerSophiya Karki, Weijing Sun, Rashna Madan, et al.
Medicine|June 1, 2017
Recombinant human granulocyte macrophage colony stimulating factor in deep second-degree burn wound healingDexiong Yan, Sha Liu, Xiaochun Zhao, et al.
Kansas Journal of Medicine|August 31, 2022
Epidermal Growth Factor Receptor Inhibitor Treatment Timing does not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective StudyBraden M Johnson, Tony A Pham, Kate J Young, et al.
International Journal of Molecular Sciences|June 28, 2023
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-AnalysisAnusha Chidharla, Eliot Rapoport, Kriti Agarwal, et al.
Cancer Biology & Medicine|September 13, 2023
CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, et al.
Journal of Hepatocellular Carcinoma|April 1, 2021
Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled TrialsRobin Park, Laercio Lopes da Silva, Voravech Nissaisorakarn, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Investigational New Drugs|January 24, 2017
A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine aloneJames M Cleary, Lee S Rosen, Kenichiro Yoshida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203Weijing Sun, Mark Powell, Peter J O'Dwyer, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 8, 2023
A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicityAnup Kasi, Pramod Gaudel, Manidhar Lekkala, et al.
JAMA Network Open|December 16, 2020
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysisAnup Kasi, Saqib Abbasi, Shivani Handa, et al.
Fortune Journal of Health Sciences|September 22, 2023
Microsatellite Instability with BRAF V600E Associated with Delayed Presentation but Poor Survival in Stage III Colorectal CancerSophiya Karki, Weijing Sun, Rashna Madan, et al.
Medicine|June 1, 2017
Recombinant human granulocyte macrophage colony stimulating factor in deep second-degree burn wound healingDexiong Yan, Sha Liu, Xiaochun Zhao, et al.
Kansas Journal of Medicine|August 31, 2022
Epidermal Growth Factor Receptor Inhibitor Treatment Timing does not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective StudyBraden M Johnson, Tony A Pham, Kate J Young, et al.
International Journal of Molecular Sciences|June 28, 2023
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-AnalysisAnusha Chidharla, Eliot Rapoport, Kriti Agarwal, et al.
Cancer Biology & Medicine|September 13, 2023
CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, et al.
Journal of Hepatocellular Carcinoma|April 1, 2021
Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled TrialsRobin Park, Laercio Lopes da Silva, Voravech Nissaisorakarn, et al.
Pageof 14